Drugmakers Face U.S. Investigation


Drug companies say the services, such as nurses and reimbursement assistance, help doctors and patients. But the practices, which have become more prevalent as drugmakers have introduced more complex and expensive drugs, are drawing scrutiny over whether they serve an illegal commercial purpose: inducing sales.



from Biotech News